A mouse model for human norovirus

mBio

Volumn 4, Issue 4, 2013, Pages

  Taube, Stefan ^a,e   Kolawole, Abimbola O ^a   Höhne, Marina ^b   Wilkinson, John E ^a   Handley, Scott A ^c   Perry, Jeffrey W ^a   Thackray, Larissa B ^c   Akkina, Ramesh ^d   Wobus, Christiane E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ROBERT KOCH INSTITUTE   (Germany)

^c WASHINGTON UNIVERSITY   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RAG1 PROTEIN; RAG2 PROTEIN; STRUCTURAL PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; FECES ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LIVER; MACROPHAGE; MOUSE; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIBLING; SPLEEN; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANIMALIA; MUS; NOROVIRUS;

EID: 84883388614     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00450-13     Document Type: Article

References (35)

1. Widdowson MA, Monroe SS, Glass RI. 2005. Are noroviruses emerging? Emerg. Infect. Dis. 11:735-737.
2. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinjé J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 14:1224-1231.
3. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. 2012. The roles of Clostridium difficile and norovirus among gastroenteritisassociated deaths in the United States, 1999-2007. Clin. Infect. Dis. 55: 216-223.
4. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15.
5. Atmar RL, Estes MK. 2006. The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. North Am. 35:275-290.
6. Scharff RL. 2010. Health related costs from foodborne illness in the United States. Georgetown University, Washington, DC.
7. Bok K, Parra GI, Mitra T, Abente E, Shaver CK, Boon D, Engle R, Yu C, Kapikian AZ, Sosnovtsev SV, Purcell RH, Green KY. 2011. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc. Natl. Acad. Sci. U. S. A. 108:325-330.
8. Cheetham S, Souza M, Meulia T, Grimes S, Han MG, Saif LJ. 2006. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J. Virol. 80:10372-10381.
9. Souza M, Azevedo MS, Jung K, Cheetham S, Saif LJ. 2008. Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J. Virol. 82:1777-1786.
10. Green KY. 2007. Caliciviridae, p 949-980. In Knipe DM, Howley PM (ed), Fields Virology, vol 1, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323.
12. Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 6:e1000831. http: //dx.doi.org/doi:10.1371/journal.ppat.1000831.
13. Bull RA, White PA. 2011. Mechanisms of GII.4 norovirus evolution. Trends Microbiol. 19:233-240.
14. CDC. 2013. Notes from the field: emergence of new norovirus strain GII.4 Sydney-United States, 2012. MMWR Morb. Mortal. Wkly. Rep. 62:55.
15. Vinjé J. 2010. A norovirus vaccine on the horizon? J. Infect. Dis. 202: 1623-1625.
16. Chan MC, Ho WS, Sung JJ. 2011. In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenum. J. Virol. 85:8427-8430.
17. Akkina R, Berges BK, Palmer BE, Remling L, Neff CP, Kuruvilla J, Connick E, Folkvord J, Gagliardi K, Kassu A, Akkina SR. 2011. Humanized Rag1-/-gammac-/-mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS One 6:e20169. doi: 10.1371/journal.pone.0020169.
18. Hoehne M, Schreier E. 2006. Detection of norovirus genogroup I and II by multiplex real-time RT-PCR using a 3=-minor groove binder-DNA probe. BMC Infect. Dis. 6:69. doi: 10.1186/1471-2334-6-69.
19. Matthews JE, Dickey BW, Miller RD, Felzer JR, Dawson BP, Lee AS, Rocks JJ, Kiel J, Montes JS, Moe CL, Eisenberg JN, Leon JS. 2012. The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup. Epidemiol. Infect. 140: 1161-1172.
20. Zaini Z, Phuektes P, McMinn P. 2012. Mouse adaptation of a subgenogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Res. 167:86-96.
21. Parker TD, Kitamoto N, Tanaka T, Hutson AM, Estes MK. 2005. Identification of genogroup I and genogroup II broadly reactive epitopes on the norovirus capsid. J. Virol. 79:7402-7409.
22. Henderson KS. 2008. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab. Anim. (NY) 37:314-320.
23. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2:e432. doi: 10.1371/journal.pbio.0020432.
24. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81:3251-3263.
25. Sestak K, Feely S, Fey B, Dufour J, Hargitt E, Alvarez X, Pahar B, Gregoricus N, Vinjé J, Farkas T. 2012. Experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses. PLoS One 7:e37973. doi: 10.1371/journal.pone.0037973.
26. Ward JM, Wobus CE, Thackray LB, Erexson CR, Faucette LJ, Belliot G, Barron EL, Sosnovtsev SV, Green KY. 2006. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol. Pathol. 34:708-715.
27. Ellermann-Eriksen S, Liberto MC, Iannello D, Mogensen SC. 1986. X-linkage of the early in vitro alpha/beta interferon response of mouse peritoneal macrophages to herpes simplex virus type 2. J. Gen. Virol. 67: 1025-1033.
28. Geist LJ, Hinde SL. 2001. Susceptibility to cytomegalovirus infection may be dependent on the cytokine response to the virus. J. Investig. Med. 49:434-441.
29. Güler ML, Gorham JD, Hsieh CS, Mackey AJ, Steen RG, Dietrich WF, Murphy KM. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984-987.
30. Chang KO, George DW. 2007. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J. Virol. 81: 12111-12118.
31. Jung K, Wang Q, Kim Y, Scheuer K, Zhang Z, Shen Q, Chang KO, Saif LJ. 2012. The effects of simvastatin or interferon-alpha on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS One 7:e41619. doi: 10.1371/journal.pone.0041619.
32. Miller H, Zhang J, Kuolee R, Patel GB, Chen W. 2007. Intestinal M cells: the fallible sentinels? World J. Gastroenterol. 13:1477-1486.
33. Honda K, Nakano H, Yoshida H, Nishikawa S, Rennert P, Ikuta K, Tamechika M, Yamaguchi K, Fukumoto T, Chiba T, Nishikawa SI. 2001. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193:621-630.
34. Luther SA, Ansel KM, Cyster JG. 2003. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J. Exp. Med. 197:1191-1198.
35. Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R. 2006. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/-(RAG-hu) mouse model. Retrovirology 3:76. doi: 10.1186/1742-4690-3-S1-S76.